NITHIODOTE (sodium nitrite and sodium thiosulfate) by Hope Pharmaceuticals is poison. Approved for acute cyanide poisoning, life-threatening. First approved in 2011.
Drug data last refreshed 6h ago · AI intelligence enriched 6d ago
NITHIODOTE is a fixed-dose combination of sodium nitrite and sodium thiosulfate administered intravenously for acute cyanide poisoning. Sodium nitrite converts hemoglobin to methemoglobin, which binds cyanide preferentially and displaces it from cytochrome oxidase; sodium thiosulfate enhances endogenous enzymatic detoxification via rhodanese-catalyzed conversion to thiocyanate. This synergistic mechanism restores aerobic cellular respiration and prevents death from rapid cyanide-induced cytotoxicity.
Peak-stage specialty/emergency product with limited market size; small, stable team focus on hospital formulary and poison control center relationships.
poison. In the absence of rapid and adequate treatment, exposure to a high dose of cyanide can result in death within minutes due to the inhibition of cytochrome oxidase resulting in arrest of cellular respiration. Specifically, cyanide binds rapidly with cytochrome a3, a component of the…
Worked on NITHIODOTE at Hope Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access patent cliff timelines and LOE dates and other premium pharma intelligence.
Upgrade to Pro — $25/moUpgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/moWorking on NITHIODOTE offers stability in a non-competitive, niche market with deep clinical impact in emergency medicine, but limited career mobility due to rare indication and small team size. This is a specialist role suited to professionals interested in toxicology, hospital relationships, and public health preparedness rather than broad commercial growth.